The notices it replaced
- Reissues: PA-13-234 Reissue PHS 2013-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
- 2 steps back: PA-13-088 PHS 2013-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
- 3 steps back: PA-12-088 PHS 2012-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
- 4 steps back: PA-11-096 PHS 2011-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
- 5 steps back: PA-10-050 PHS 2010-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
- 6 steps back: PA-09-080 PHS 2009-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
Replaced by PA-15-269.
Who won it before
1,462 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $497,510,394 in first-year total cost, median $224,965.
Most frequent study sections
- Special Emphasis Panel[ZRG1 ETTN-G (12)]89
- Special Emphasis Panel[ZRG1 ETTN-M (11)]86
- Special Emphasis Panel[ZRG1 SBIB-T (10)]71
- Special Emphasis Panel[ZRG1 IMST-L (11)]65
- Special Emphasis Panel[ZRG1 IMST-M (13)]59
Most frequent institutions
- PANORAMA RESEARCH, INC.16
- PROGENRA, INC.11
- AFFINERGY, LLC10
- PHYSICAL SCIENCES, INC9
- 3-C INSTITUTE FOR SOCIAL DEVELOPMENT8
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2016 | Characterization of a low mutation rate E. coli in extended fermentation2R44GM105177-02 | BLATTNER, FREDERICK RFRISCH, DAVID A | SCARAB GENOMICS, LLC, WI | $1,554,424 | ZRG1 |
| 2016 | Arenavirus Antiviral Lead Optimization2R44AI112097-03 | HENKEL, GREGORY WILLIAMPLEWE, MICHAEL BRUNO | ARISAN THERAPEUTICS, INC., CA | $1,500,000 | ZRG1 |
| 2016 | Novel drug VS-105 for treatment of osteoporosis2R44AR065247-02 | WU-WONG, JINSHYUN RUTH | VIDASYM, INC., SD | $1,480,983 | ZRG1 |
| 2016 | A Vaccine for Schistosomiasis, "SchistoShield"2R44AI103983-03A1 | CARTER, DARRICK ALBERTSIDDIQUI, AFZAL A | PAI LIFE SCIENCES, INC., WA | $1,159,786 | ZRG1 |
| 2016 | Improving red blood cell transfusion through systems biology2R44HL123074-02 | BORDBAR, AARASH | SINOPIA BIOSCIENCES, INC., CA | $1,029,290 | ZRG1 |
| 2016 | Customized Nanotechnology Based Treatment of Oral Cancer2R44DE023725-02 | GOLDBERG, MANIJEH N | PRIVO TECHNOLOGIES, LLC, MA | $999,997 | ZRG1 |
| 2016 | Preventing and treating RSV pneumonia in immunocompromised cancer patients2R44HL118926-02 | SCOTT, BRENTON | PULMOTECT, INC, TX | $999,372 | ZRG1 |
| 2016 | Low Insertion Force Epidural, Actuated Needle System for Enhanced Control and Tactile Feel During Epidural Insertion2R44GM085844-04A1 | MULVIHILL, MAUREEN L. | ACTUATED MEDICAL, INC., PA | $898,850 | ZRG1 |
| 2016 | Kinome-wide Cell-Based Assays2R44GM109740-02 | ZUTSHI, REENA | LUCEOME BIOTECHNOLOGIES, LLC, AZ | $873,704 | ZRG1 |
| 2016 | Novel DNA-Launched Attenuated Vaccine for VEE Virus SBIR Phase II2R44AI094863-03A1 | PUSHKO, PETER M. | MEDIGEN, INC., MD | $811,565 | ZRG1 |
| 2016 | Novel Therapeutic Approach to Hypercholesterolemia Using Anti-PCSK9 Selected Immune Repertoires2R44HL121909-02 | SHIMKETS, RICHARD AUGUST | ABEOME CORPORATION, GA | $809,592 | ZRG1 |
| 2016 | Safety Studies for Clinical Trials of a Botanical Drug for Sickle Cell Disease2R44HL119086-02 | SWIFT, ROBERT | INVENUX, LLC, CO | $807,410 | ZRG1 |
| 2016 | A high throughput, high resolution, and high sensitivity scanning X-ray fluorescence microprobe for elemental mapping in cell cultures and tissues for medical research and diagnosis2R44GM112413-02 | YUN, WENBING | SIGRAY, INC., CA | $759,237 | ZRG1 |
| 2016 | A Web-Enabled Database for Rapid Metagenomic Biocatalyst Discovery and Validation2R44GM113357-02 | KIM, JEFFREY | RADIANT GENOMICS, INC., CA | $749,000 | ZRG1 |
| 2016 | Chemical Optimization of a novel class of USP7 inhibitor for cancer treatment2R44CA174037-02 | WEINSTOCK, JOSEPH | PROGENRA, INC., PA | $748,944 | ZRG1 |
| 2016 | Enhancing protective antibody responses for a DNA/MVA HIV vaccine2R44AI106422-03 | ROBINSON, HARRIET L | GEOVAX, INC., GA | $740,456 | VACC |
| 2016 | Novel Mucosal Adjuvant for an HIV DNA Vaccine2R44AI089290-02 | BAGLEY, KENNETH C | PROFECTUS BIOSCIENCES, INC., MD | $733,632 | VACC |
| 2016 | sEH Inhibitors to Treat Neuropathic Pain2R44ES025598-02 | BUCKPITT, ALAN RHAMMOCK, BRUCE D | EICOSIS, LLC, CA | $731,876 | ZRG1 |
| 2016 | PEPTIDE BEAD MICROARRAYS MEASURED BY MASS SPECTROMETRY IMAGING2R44GM103348-03 | BERGO, VLADISLAV | ADEPTRIX CORPORATION, MA | $720,069 | ZRG1 |
| 2016 | Portable nanofluidic aptamer-SERS instrument for measurement of chemical exposure2R44ES022303-02 | JACKSON, GEORGE W | BIOTEX, INC., TX | $714,230 | ZRG1 |
| 2016 | Long Term Pulse Oximeter Monitoring for Neonates with Chronic Disease2R44HL112460-02A1 | GIBSON, PAUL L | ADVANCED MEDICAL ELECTRONICS CORPORATION, MN | $693,210 | ZRG1 |
| 2016 | TriadWeb: An easy-to-use web-based platform for protein engineering2R44GM113542-02 | OLAFSON, BARRY D | PROTABIT, LLC, CA | $649,727 | ZRG1 |
| 2016 | An In Vitro Human Small Intestine Tissue Model for Drug Permeation Studies2R44GM108164-02 | AYEHUNIE, SEYOUM | MATTEK CORPORATION, MA | $648,815 | ZRG1 |
| 2016 | On Site Mercury Remediation via Activated Fly Ash2R44ES024620-02 | KRUTKRAMELIS, KASPARS | POLLUTION CONTROL TECHNOLOGIES, LLC, WY | $636,186 | ZRG1 |
| 2016 | Brain Injury Support and Strategies for Families Impacted by Childhood TBI2R44HD059255-02A1 | GLANG, ANN EKEATING, THOMAS JOSEPH | ASSISTECH SYSTEMS, LLC, OR | $621,061 | ZRG1 |
| 2016 | Dynamic Perturbation Training System for ACL Rehabilitation2R44HD068054-04 | CHU, JEFFREY J.GREENWALD, RICHARD MSNYDER-MACKLER, LYNN | SIMBEX, LLC, NH | $620,150 | MRS |
| 2016 | Developing small molecule inhibitors of TLR8 for treatment of rheumatoid arthritis2R44AI100376-03 | CANDIA, ALBERT F | DYNAVAX TECHNOLOGIES CORPORATION, CA | $589,482 | ZRG1 |
| 2016 | A Probabilistic Pose Estimation Algorithm for 3D Motion Capture Data2R44HD066831-02A1 | SELBIE, W. SCOTT | C-MOTION, INC., MD | $556,711 | ZRG1 |
| 2016 | Size-Resolved Measurement of Ultrafine and Nanometer Particle Concentrations2R44OH010515-02A1 | HERING, SUSANNE VERA | AEROSOL DYNAMICS, INC., CA | $524,614 | ZRG1 |
| 2016 | Capti Screen Reading Assistant for Goal Directed Web Browsing2R44EY021962-02A1 | BORODIN, YEVGEN | CHARMTECH LABS, LLC, NY | $500,000 | ZRG1 |
| 2016 | Myocardial blood flow quantitation with the novel PET F-18 Fluripidaz imaging tracer2R44HL123069-02 | MADDAHI, JAMSHIDVAN TRAIN, KENNETH | SYNTERMED, INC,, GA | $499,632 | ZRG1 |
| 2016 | GammaPNA Miniprobes for Telomere Analysis and RNA FISH2R44GM108187-03 | ARMITAGE, BRUCE A.OPRESKO, PATRICIA LSRIVASTAVA, TUMUL | PNA INNOVATIONS, INC., MA | $484,541 | ZRG1 |
| 2016 | Correctional Officer Distress Alarm Phase II2R44OH010008-02A1 | SCHANTZ, HANS GREGORY | Q-TRACK CORPORATION, AL | $474,161 | ZRG1 |
| 2016 | Virus-targeted therapeutic for EBV-Associated Malignancies2R44CA153474-02A1 | PERRINE, SUSAN PARK | PHOENICIA BIOSCIENCES, INC., MA | $472,008 | ZRG1 |
| 2016 | PTSD_Monitoring_System_For_Prolonged_Exposure_Therapy1R43MH107089-01A1 | BLY, MARK | ACLARIS MEDICAL, LLC, MN | $449,996 | ZRG1 |
| 2016 | Synthesis of bone-selective osteogenic oxysterols2R44AR065148-02A1 | STAPPENBECK, FRANK | MAX BIOPHARMA, INC., CA | $448,646 | ZRG1 |
| 2016 | Noninvasive scalp detection of cortical spreading depression for brain injury1R43NS092181-01A1 | JONES, STEPHEN CARTER | SCIENCEPLUSPLEASE, LLC, PA | $349,466 | ZRG1 |
| 2016 | Tools for drug efficacy studies in perfused tissue models1R43TR001286-01A1 | VUKASINOVIC, JELENA | LENA BIOSCIENCES, INC., GA | $325,000 | ZRG1 |
| 2016 | NMDA RECEPTOR MODULATORS AS NOOTROPIC THERAPIES IN AGING BRAIN1R43AG051299-01 | GROSS, AMANDA | APTINYX, INC., IL | $311,866 | ZRG1 |
| 2016 | A New Treatment to Reduce Scarring1R43GM117990-01 | SLEE, DEBORAH | KALYRA PHARMACEUTICALS, INC., CA | $306,161 | ZRG1 |
| 2016 | SIRTUIN AGONISTS AS PAN INFLUENZA ANTIVIRALS1R44AI122488-01 | REMISZEWSKI, STACY | EVRYS BIO, LLC, PA | $304,858 | ZRG1 |
| 2016 | Novel beta-lactams as inhibitors of ebola virus infections1R43AI122465-01 | ARON, ZACHARY DAVID | MICROBIOTIX, INC, MA | $304,394 | ZRG1 |
| 2016 | Mouth barrier rinse of sustained-release poly(curcumin) to treat oral mucositis2R44DE023523-02A1 | BHANDARI, ROHIT | BLUEGRASS ADVANCED MATERIALS, LLC, KY | $303,779 | ZRG1 |
| 2016 | Novel Bone-Targeting Combination Therapy for Osteosarcoma1R43CA203166-01 | ZINNEN, SHAWN PATRICK | MBC PHARMA, INC., CO | $301,877 | ZRG1 |
| 2016 | Development of a Non-adjuvanted VLP Vaccine against Stealth H7N9 Influenza1R43AI118189-01A1 | DEGROOT, ANNE SEARLS | EPIVAX, INC., RI | $300,000 | ZRG1 |
| 2016 | Novel Trypanocidal Compounds for the Treatment of Stage 1 and 2 HAT.1R43AI122475-01 | HOWARD, HARRY RALPH | MEDISYNERGICS, LLC, CT | $299,998 | ZRG1 |
| 2016 | Immuno-Oncology for Pancreatic Cancer: A Combination Clinical Trial with Chemotherapy and Radiation1R44CA203336-01 | AGUILAR, LAURA KAGUILAR-CORDOVA, ESTUARDO | ADVANTAGENE, INC, MA | $299,985 | ZRG1 |
| 2016 | Development of an Indicator Cell Assay for blood-based diagnosis of lung cancer1R43CA203455-01 | SMITH, JENNIFER JOY | PRECYTE, INC., MD | $299,947 | ZRG1 |
| 2016 | Sequencing of Epigenetic Modifications from Single Cells1R43HG008568-01A1 | TOLOUE, MASOUD | BIOO SCIENTIFIC CORPORATION, TX | $298,940 | ZRG1 |
| 2016 | Production of Image-Guided Metastatic Melanoma Therapy Radiopharmaceuticals1R43CA203430-01 | JOHNSON, FRANCES L | VIEWPOINT MOLECULAR TARGETING, INC., IA | $298,530 | ZRG1 |
| 2016 | Genetic Cytology for Ovarian and Endometrial Cancer Screening1R44CA203350-01 | KINDE, ISAAC A | PAPGENE, INC., MD | $296,784 | ZRG1 |
| 2016 | Stabilized Prasugrel enantiomers for pediatric sickle cell disease1R43HL131158-01 | DEWITT, SHEILA | DEUTERX, LLC, NH | $294,508 | ZRG1 |
| 2016 | An improved RT-qPCR method for quantitation of fragmented mRNAs1R43GM117873-01 | KAZAKOV, SERGEI A | SOMAGENICS, INC., CA | $287,788 | ZRG1 |
| 2016 | Development of BA-1049 for treatment of cerebral cavernous malformation1R44NS095420-01 | AWAD, ISSAM AMARCHUK, DOUGLAS A.MCKERRACHER, LISA JSTOCKTON, REBECCA A | BIOAXONE BIOSCIENCES, INC., MA | $280,625 | ZRG1 |
| 2016 | A Rapid, High Performance, Cost-Efficient Clinical Scale Separator for CD3+ cells1R43HL131402-01 | LIBERTI, PAUL A | BIOMAGNETIC SOLUTIONS, LLC, PA | $279,216 | ZRG1 |
| 2016 | A New Small Molecule Targeted Therapeutic for Acute Myeloid Leukemia1R43CA203172-01 | MU, XUEYAN | TEAMEDON INTERNATIONAL, INC., MD | $278,000 | ZRG1 |
| 2016 | Microfluidic assay to predict patient-specific multiple myeloma clinical response1R43CA203441-01 | PAK, CHOROM | LYNX BIOSCIENCES, LLC, CA | $268,841 | ZRG1 |
| 2016 | nNOS-PSD95 inhibitors as novel treatments for TBI1R43NS095489-01 | LAI, YVONNE Y. | ANAGIN, IN | $267,381 | ZRG1 |
| 2016 | Transcutaneous Neuromodulation at Acupoint for Gastric Complications of Scleroderma1R43AT008634-01A1 | YIN, JIEYUN NONE | TRANSTIMULATION RESEARCH, INC., OK | $265,665 | ZRG1 |
| 2016 | Optimizing active site inhibitor of CaMKII: A Novel Target in Atrial Fibrillation1R43HL131089-01 | SCHULMAN, HOWARD | ALLOSTEROS THERAPEUTICS, INC., CA | $249,025 | ZRG1 |
| 2016 | A product for osteoarthritis treatment and prevention1R43AT009041-01 | LEONG, DANIEL JSUN, HUI BIN | NEW YORK/R&D/CTR/TRANSLATIONAL MED/THER, NY | $243,994 | ZRG1 |
| 2016 | In Vivo Efficacy Studies of Clofazimine against CDAD in Hamster Model1R43AI122531-01 | VEDBRAT, SHARANJIT KS | KAMTEK, INC., MD | $240,553 | ZRG1 |
| 2016 | Stimuli-responsive reagents for improved cell isolations and activations1R43AI122512-01 | NEHILLA, BARRETT J | NEXGENIA, INC., WA | $232,149 | ZRG1 |
| 2016 | Development of Self-Expanding Foams for Percutaneous Damage Control of Retroperitoneal Pelvic Exsanguination1R44GM117849-01 | SHARMA, UPMA | ARSENAL MEDICAL, INC., MA | $227,667 | ZRG1 |
| 2016 | Patient/Resident Mobility Tracker (PREEMPT)1R43NR015934-01 | PARKER, B EUGENE | BARRON ASSOCIATES, INC., VA | $226,820 | ZRG1 |
| 2016 | PINPOINT: Gaming technology to engage adolescent sickle cell patients in precision pain management1R43MD010746-01 | MYERS, VALERIE H | KLEIN BUENDEL, INC., CO | $226,154 | ZRG1 |
| 2016 | Development of a Novel Therapeutic for Diabetic Retinopathy1R43EY026281-01 | MOVSAS, TAMMY Z | ZIETCHICK RESEARCH INSTITUTE, LLC, MI | $225,000 | ZRG1 |
| 2016 | Discovery of Novel Pharmaceutical Agents for Skeletal Muscle Atrophy1R43AR069400-01 | ADAMS, CHRISTOPHER MEBERT, SCOTT MATTHEWTALLEY, JOHN JEFFREY | EMMYON, INC., MN | $225,000 | ZRG1 |
| 2016 | A novel genotoxicity assay incorporating the toxicogenomics biomarker TGx-28.65 with a direct digital counting1R43ES026473-01 | GEORGE, JAY | TREVIGEN, INC., MD | $225,000 | ZRG1 |
| 2016 | Enzyme Replacement Therapeutics for Rare Childhood Genetic Diseases: An ERT Delivery System that Mitigates Immune-sensitization1R43HD087099-01 | ACOSTA, WALTERCRAMER, CAROLE L.RADIN, DAVID | BIOSTRATEGIES, LC, AR | $225,000 | ZRG1 |
| 2016 | Lab-on-a-Chip-Based System for Detection and Monitoring of Oral Cancer in Dental Settings1R44DE025798-01 | MCDEVITT, JOHN TMEHALSO, ROBERT | SENSODX II, LLC, NY | $224,990 | ZRG1 |
| 2016 | Screening for pancreatic cancer via nanocytology of duodenal cells1R43CA200052-01A1 | CHERKEZYAN, LUSIK SURENOVNASUBRAMANIAN, HARIHARAN | NANOCYTOMICS, LLC, IL | $224,986 | ZRG1 |
| 2016 | Novel Aminoadamantane Nitrates for the Treatment of Neurological Diseases1R43AG054406-01 | LARRICK, JAMES W | PANORAMA RESEARCH, INC., CA | $224,981 | ZRG1 |
| 2016 | Cough sample collection and processing for the diagnosis of pulmonary TB1R43HL128120-01A1 | CHAPMAN, STEPHENELMARAACHLI, WAEL | DETON CORPORATION, CA | $224,981 | ZRG1 |
| 2016 | AN OPEN WEB SERVICE FOR FRAGMENT-BASED DESIGN OF SMALL MOLECULE INHIBITORS1R43GM109549-01A1 | KULP, JOHN L | CONIFER POINT PHARMACEUTICALS, LLC, PA | $224,972 | ZRG1 |
| 2016 | Novel tools for site-specific ablation of the mitochondrial genome1R43GM117965-01 | RUIZ, JOSEPH C. | ENZERNA BIOSCIENCES, LLC, NC | $224,968 | ZRG1 |
| 2016 | rhMFG-E8 as an Effective Adjuvant Therapy for Hemorrhagic Shock1R43HL129543-01A1 | YANG, WENG-LANG | THERASOURCE, LLC, NY | $224,951 | ZRG1 |
| 2016 | Compact Point-of-Care Aptamer-Based Sensor for Detection of Oral Disease Biomarkers in Saliva1R43DE025153-01A1 | MCDONALD, ROBERT C | GINER, INC., MA | $224,916 | ZRG1 |
| 2016 | An easy-to-use and powerful tool for improved Rosetta comparative modeling of proteins1R43GM116233-01A1 | SONG, YIFAN | CYRUS BIOTECHNOLOGY, INC., WA | $224,908 | ZRG1 |
| 2016 | Small Molecule Treatments to Enhance Stroke Recovery1R43NS095381-01 | FINKLESTEIN, SETH P | STEMETIX, INC., MA | $224,904 | ZRG1 |
| 2016 | Rapid Molecular Detection of Tuberculosis without PCR amplification1R43AI122527-01 | CELEDON, ALFREDO ANDRES | SCANOGEN, INC., MD | $224,890 | ZRG1 |
| 2016 | Targeting galectin-3 for prostate cancer therapy1R43CA203420-01 | AHMED, HAFIZ | GLYCOMANTRA, INC., MD | $224,881 | ZRG1 |
| 2016 | Design and Validation of a Commercially Viable IVUS/IVPA Imaging System1R43HL129725-01A1 | KARPIOUK, ANDREI | DECISIV INTERVENTIONS, LLC, TX | $224,848 | ZRG1 |
| 2016 | Small Diameter, High Output, Durable Transapical LVAD1R43HL127784-01A1 | SMITH, WILLIAM A | PERFUSION SOLUTIONS, INC., OH | $224,826 | ZRG1 |
| 2016 | A high brightness microstructured anode X-ray source for clinical phase contrast imaging1R44EB023284-01A1 | YUN, WENBING | SIGRAY, INC., CA | $224,812 | ZRG1 |
| 2016 | Quantitative Photoacoustic Microscopy for Cancer Immunohistochemistry1R43CA196101-01A1 | COOK, JASON | NANOHYBRIDS, INC., TX | $224,614 | ZRG1 |
| 2016 | High-throughput methyltransferase assays using recombinant nucleosome substrates1R43GM117683-01 | SUN, ZU-WEN | EPICYPHER, INC., NC | $224,504 | ZRG1 |
| 2016 | Targeted Nano-enhanced Optical Delivery of opsin for dry-AMD therapy1R43EY026483-01 | WRIGHT, WELDON | NANOSCOPE TECHNOLOGIES, LLC, TX | $224,370 | ZRG1 |
| 2016 | eHealth Intervention for Postpartum Depression in Healthcare Settings1R43MH109191-01 | DANAHER, BRIAN G.SMITH, DAVID RANDOLPH | OREGON RES BEHAVIORAL INTERVENTION STRAT, OR | $224,332 | ZRG1 |
| 2016 | A Quad-Fast-MAS probe for Dramatically Improved Biomolecular Structure Determinations1R43GM117905-01 | DOTY, FRANCIS DAVID | DOTY SCIENTIFIC, INC., SC | $224,326 | ZRG1 |
| 2016 | Biopsy Probes with Real-time Multi-modality Image Guidance for Peripheral Lung Nodules1R43CA203033-01 | VERTIKOV, ANDREI | LX MEDICAL CORPORATION, MA | $224,283 | ZRG1 |
| 2016 | An adjunct to prolonged exposure therapy for treating refractory PTSD patients1R43MH105014-01A1 | ENGINEER, NAVZERMCINTYRE, CHRISTA | MICROTRANSPONDER, INC., TX | $224,257 | ZRG1 |
| 2016 | An Epitope-Focused Pediatric RSV Vaccine1R43AI122370-01 | MILICH, DAVID R.WHITACRE, DAVID C | VLP BIOTECH, INC., CA | $224,141 | ZRG1 |
| 2016 | Clinical optical coherence tomography for retinal metabolic imaging1R43EY026466-01 | RADOSEVICH, ANDREW JOSEPH | OPTICENT, INC., IL | $224,139 | ZRG1 |
| 2016 | MyoFit: A new approach to suspension for upper limb myoelectric prostheses1R44HD087065-01 | KALIKI, RAHUL REDDYLAKE, CHRISTOPHER JTHAKOR, NITISH VYOMESH | INFINITE BIOMEDICAL TECHNOLOGIES, LLC, MD | $223,804 | ZRG1 |
| 2016 | Treatment of alcoholic liver disease with novel targeted inhibitors1R43AA024355-01A1 | SIGALOV, ALEXANDER B | SIGNABLOK, INC., MA | $223,443 | ZRG1 |
| 2016 | Flowable antimicrobial skin scaffolding matrix that promotes regeneration1R43GM117858-01 | MEHTA, MANAV | GEL4MED, INC., MA | $223,369 | ZRG1 |
| 2016 | The Variant Explorer: a cloud-based data integration and visualization system for improving clinical interpretation of sequenced genetic variants.1R43GM117644-01 | XU, XING | SOLVE, INC., NY | $223,181 | ZRG1 |
| 2016 | Rapid Nucleic Acid Test for Chlamydia in Resource Limited Settings1R43EY026324-01 | SUBRAMANIAN, KUMAR | PHOENIX BIOSYSTEM, INC., CA | $222,674 | ZRG1 |
| 2016 | Acoustic lysis and extraction system for limited cell number applications1R43GM117932-01 | IVANOV, ALEXANDER R.KELLOGG, GREGORY JOHN | COVARIS, INC., MA | $222,481 | ZRG1 |
| 2016 | Commercialization of Integrated Continuous and Single-use Bio-production Capture Platform (ICS)1R44GM117682-01 | SHINKAZH, OLEG | CHROMATAN CORPORATION, MA | $222,379 | ZRG1 |
| 2016 | Development of a Topical Treatment for Cataract1R43EY026474-01 | MAKLEY, LEAH NICOLE | VIEWPOINT THERAPEUTICS, INC., CA | $221,978 | ZRG1 |
| 2016 | A Next Generation, Low Cost Tracking System for Healthcare1R43NR015928-01 | SCHANTZ, HANS GREGORY | Q-TRACK CORPORATION, AL | $221,816 | ZRG1 |
| 2016 | Better Living After Stroke through Technology (BLAST)1R44NR016183-01 | WOLF, TIMOTHY J.YANG, DERSHUNG | BRIGHTOUTCOME INC., IL | $221,664 | ZRG1 |
| 2016 | Low Cost Hand-held Device and Software to Predict Pressure Ulcer Formation1R43NR015946-01 | GASPARD, SANNA L | RUBITECTION, INC., PA | $221,415 | ZRG1 |
| 2016 | Targeting the plasma high density lipoprotein (SR-B1) receptor for effective anti-cancer therapeutics.1R43CA203170-01 | MCCONATHY, WALTER J | LIPOMEDICS, INC., TX | $220,726 | ZRG1 |
| 2016 | Selective inhibition of platelet GPIb-alpha binding to leukocyte Mac-1 as a novel anti-thrombotic therapeutic1R43HL131180-01 | BOYLE, WILLIAM JAMES | BIOATLA, LLC, CA | $220,268 | ZRG1 |
| 2016 | An Innovative Device Integrating Cryopreservation, Storage, and Artificial Insemination of Mouse Sperm1R43OD020304-01A1 | STONE, BARBARA JEAN | PARATECHS CORP., KY | $220,199 | ZRG1 |
| 2016 | Integrated sample collection-to-preparation platform for multianalyte POC detection1R43AI122474-01 | BERTHIER, ERWIN | TASSO, INC., WA | $220,000 | ZRG1 |
| 2016 | A smartphone-based point-of-care test for detection of Chlamydia trachomatis1R43AI118180-01A1 | PATERSON, ANDREW SLATORWILLSON, RICHARD | LUMINOSTICS, INC., CA | $218,522 | ZRG1 |
| 2016 | Novel avian CCR5 specific antibodies to block HIV transmission1R43AI122974-01 | HARRIMAN, BILL DON | CRYSTAL BIOSCIENCE, INC., CA | $216,897 | ZRG1 |
| 2016 | Novel Platform for Improving Access to and Efficacy of Fertility Treatments1R43HD086922-01 | STERN, ERIC | SELUX DIAGNOSTICS, INC., MA | $216,546 | ZRG1 |
| 2016 | Deconvolution and Assembly of Metgenomes Using Chromatin Conformation Capture1R43AI122654-01 | LIACHKO, IVAN | PHASE GENOMICS, INC., WA | $216,192 | ZRG1 |
| 2016 | Hand Hygiene for Patients1R43NR015948-01 | LANE, STEPHENLIPSETT, PAMELA ANN | STARGATES, INC., VA | $216,004 | ZRG1 |
| 2016 | High-throughput nanoMEA-based Proarrhythmia Assay1R43HL131169-01 | SMITH, ALEC SIMON TULLOCH | CURI BIO INC, WA | $214,000 | ZRG1 |
| 2016 | A RAPID ASSAY FOR DETECTION OF DETECTION OF CARBAPENEMASE PRODUCING ORGANISMS1R43AI122464-01 | CARROLL, KAREN C.LI, XING-XIANG | CELLEX, INC., NC | $213,341 | ZRG1 |
| 2016 | Living with CDK: An E-Learning Platform for Adolescents with CKD about the Disease and its Management1R43DK108421-01 | CHILDRESS, DEBRAFERRIS, MARIA E. | 3-C INSTITUTE FOR SOCIAL DEVELOPMENT, NC | $210,222 | ZRG1 |
| 2016 | A recombinant protein that increases engraftment of hematopoietic stem cells1R43HL131195-01 | CARTER, DARRICK ALBERT | PAI LIFE SCIENCES, INC., WA | $208,639 | ZRG1 |
| 2016 | A Holographic Waveguide Display Based Low Vision Eyewear1R43EY026265-01 | LI, YUNJINGLIU, LEI | BIOLIGHT ENGINEERING, LLC, IL | $205,632 | ZRG1 |
| 2016 | Geostatistical software for spatial and multi-dimensional joinpoint regression analysis of time series of health outcomes1R43CA192520-01A1 | GOOVAERTS, PIERRE E | BIOMEDWARE, MI | $204,574 | ZRG1 |
| 2016 | An Automated Device for High Yield Mesenchymal Stem Cell Extraction1R43OD021447-01 | ELMASRI, HARUNHUANG, LOTIEN RICHARD | CG SCIENTIFIC, INC., MA | $199,850 | ZRG1 |
| 2016 | Massively parallel quantitative single-cell PCR with qCell Arrays1R43GM117742-01 | EASTBURN, DENNIS J | MISSION BIO, INC., CA | $199,665 | ZRG1 |
| 2016 | Low Cost Microphysiological System for Improved Pharmacodynamics1R43GM117954-01 | MCCLELLAND, RANDALL EDWIN | SCIKON INNOVATION, INC., NC | $199,623 | ZRG1 |
| 2016 | Development of a Universal Influenza Vaccine Produced by Cell-Free Protein Synthesis1R43AI122375-01 | FAIRMAN, JEFF C | VAXCYTE, INC., CA | $196,063 | ZRG1 |
| 2016 | Assessment of Dopaminergic Impact and Development of Clinical Biomarker for Fragile X Syndrome1R43NS095422-01 | CHEN, HAO | DRI BIOSCIENCES CORPORATION, MD | $192,852 | ZRG1 |
| 2016 | VALIDATION OF AN IN VITRO ASSAY FOR ANDROGENIC ACTIVITY1R44ES026470-01 | YANG, CATHY Z | CERTICHEM, INC., TX | $192,803 | ZRG1 |
| 2016 | Optical imaging of a CD44-based oral-rinse with fluorescent detection to visualize oral cancer1R43DE025797-01 | FRANZMANN, ELIZABETH JREIS, ISILDINHA MARQUES | VIGILANT BIOSCIENCES, INC., FL | $191,538 | ZRG1 |
| 2016 | Noninvasive collection of cell and region specific miRNA from heterogeneous tissues.1R43GM116343-01A1 | KARSTEN, STANISLAV | NEUROINDX INC., CA | $190,311 | ZRG1 |
| 2016 | Fenofibrate Eye Drop for the Treatment of Diabetic Retinopathy1R43EY026326-01 | WASSEL, RONALD A | CHARLESSON, LLP, OK | $185,550 | ZRG1 |
| 2016 | Development of a Renal Sympathetic Nerve Activity Monitoring Device1R43DK105642-01A1 | VENKATESWARA-RAO, KONDAPAVULUR T | NORTHWIND MEDICAL, INC., CA | $179,155 | ZRG1 |
| 2016 | Efficient Characterization of DNA-Protein Binding using a High-Throughput Sequencer1R43GM117929-01 | MCPIKE, MARK PATRICK | APTAMATRIX, INC., NY | $176,785 | ZRG1 |
| 2016 | Peptide-based Multiplex Assay for Lyme disease Serodiagnosis1R43AI122399-01 | ARNABOLDI, PAUL MICHAEL | BIOPEPTIDES, INC., CT | $176,282 | ZRG1 |
| 2016 | Engineered aldolase for the fermentative production of L-fucose and other rare sugars.1R43GM116270-01 | BANNAI, YUKA | ZUCHEM, INC., IL | $175,813 | ZRG1 |
| 2016 | Automation of a Liver Genotoxicity Assay1R44ES026464-01 | BEMIS, JEFFREY CDERTINGER, STEPHEN D | LITRON LABORATORIES, LTD., NY | $172,590 | ZRG1 |
| 2016 | On-Line Reading Instruction Dynamically Adapted to Low-Achieving Students’ Motivation and Engagement1R43HD082850-01A1 | SPICHTIG, ALEXANDRA | TAYLOR ASSOCIATES COMMUNICATIONS, INC., VT | $171,137 | ZRG1 |
| 2016 | Additive Manufacturing of Ceramic Dental Restorations1R43DE025803-01 | ZIMBECK, WALTER | TECHNOLOGY ASSESSMENT AND TRANSFER, INC., MD | $170,953 | ZRG1 |
| 2016 | iMedPAL: Improving Medical Prescription Adherence by Leveraging Mobile Technology1R43AI118114-01A1 | HIRSCHMAN, GORDON BMCKENNA, KRISTINE | VIVONICS, INC., MA | $166,793 | ZRG1 |
| 2016 | Web-Based Alcohol Misuse Prevention Intervention for the Elderly1R44AA024349-01 | DEITZ, DIANE K. | ISA ASSOCIATES, INC., VA | $161,508 | ZRG1 |
| 2016 | Development of a GABA Enzyme for Biosensor and Point-of-Care Applications1R43MH109188-01 | JOHNSON, DAVID A | PINNACLE TECHNOLOGY, INC, KS | $153,963 | ZRG1 |
| 2016 | New Ionization Technique for MS Imaging1R43GM116492-01 | MOSKOVETS, EUGENE | MASSTECH, INC., MD | $150,000 | ZRG1 |
| 2016 | Flexible, Graphene-based Detector Arrays for Petrochemical Exposure Monitoring1R43OH010881-01A1 | PATEL, SANJAY V | SEACOAST SCIENCE, INC., CA | $150,000 | ZRG1 |
| 2016 | Pulse Oximeter Innovation to Measure Pulsus Paradoxus and Respiratory Disease Severity1R43HL131165-01 | ARNOLD, DONALD HAYESPOLOGE, JONAS ALEXANDER | KESTREL LABS, INC., CO | $150,000 | ZRG1 |
| 2016 | SBIR PHASE I: HIGH-CAPACITY MULTIMODAL ANION-EXCHANGE MEMBRANES FOR PURIFICATION OF BIOLOGICS1R43GM117685-01 | ZHOU, JINXIANG | PURILOGICS, LLC, SC | $150,000 | ZRG1 |
| 2016 | Nanotechnology-Based Environmental Smart Sensors for Personal Health Exposure Monitoring1R43ES026500-01 | NAISHADHAM, KRISHNA | WI-SENSE, LLC, GA | $150,000 | ZRG1 |
| 2016 | Development Novel Acoustic Processing for Cryoprotectant Removal and Cell Enrichment in Cellular Therapy1R43GM117955-01 | GATEWOOD, JOE M. | ACOUSTIC BIOSYSTEMS, INC., NM | $150,000 | ZRG1 |
| 2016 | Low Cost Personal Sampling Pump1R43OH010635-01A1 | MILLER-LIONBERG, DANIEL D | ACCESS SENSOR TECHNOLOGIES, LLC, CO | $149,999 | ZRG1 |
| 2016 | Rapid, High Yield, Single-Tube Nucleic Acid Extraction at Low Temperature using Lateral Ultrasonic Wave Transducer1R43HG008908-01 | SANSANWAL, POONAMVIVEK, VIBHU | MICROSONIC SYSTEMS, INC., CA | $149,999 | ZRG1 |
| 2016 | CRISPR-based anti-viral therapeutics to eliminate EBV-associated post-transplant lymphoproliferative disease1R43AI122529-01 | XIONG, XIN CINDY | AGENOVIR CORPORATION, CA | $149,972 | ZRG1 |
| 2016 | Fast and automated DNA and RNA extraction from formalin-fixed, paraffin-embedded tissue1R43HG008926-01 | HIDDESSEN, AMY | PURIGEN BIOSYSTEMS, INC., CA | $149,960 | ZRG1 |
| 2016 | Drug Abuse Policy Surveillance System1R43DA040340-01 | BURRIS, SCOTT CULLENLEE, MARGARET S | LEGAL SCIENCE PARTNERS, LLC, PA | $149,834 | ZRG1 |
| 2016 | A new method for long-range haplotype phasing with short-read sequencing data.1R43HG008924-01 | BLANCHETTE, MARCO | DOVETAIL GENOMICS, LLC, CA | $149,786 | ZRG1 |
| 2016 | Tremor-Corrective Handheld Manipulator for Vitreoretinal Microsurgery1R43EY026304-01 | PIAZZA, DANIELE | NEW SCALE TECHNOLOGIES, INC., NY | $149,330 | ZRG1 |
| 2016 | Advanced Magnetic Pickup Hearing Aids1R43DC014236-01A1 | NORDMAN, CATHERINE | NONVOLATILE ELECTRONICS, INC. (NVE), MN | $149,036 | ZRG1 |
| 2016 | Articulating Video Stylet for Improved Intubation Success Rates1R43HL124724-01A1 | MCCORMICK, LAURA L. | BRIO DEVICE, LLC, MI | $147,652 | ZRG1 |
| 2016 | Production of immunogenic Ebola GP protein in maize1R43CK000493-01A1 | EGELKROUT, ERIN | APPLIED BIOTECHNOLOGY INSTITUTE, CA | $147,275 | ZRG1 |
| 2016 | Rapid Paper-based Diagnostics of CT / Trich1R43AI122497-01 | KLAPPERICH, CATHERINE M.ZHANG, JANE | MICRO ANALYSIS INTEGRATION, LLC, CA | $147,247 | ZRG1 |
| 2016 | SAMPLE PREPARATION; The Achilles Heel of Mass Spectrometry Based Diagnostics1R43GM116663-01 | REGNIER, FRED E | NOVILYTIC, LLC, IN | $147,170 | ZRG1 |
| 2016 | Efficient Creation of Long-Template Libraries for Next-Generation Sequencing1R43CA196134-01A1 | METZKER, MICHAEL L. | REDVAULT BIOSCIENCES, LP, TX | $146,801 | ZRG1 |
| 2016 | A Formaldehyde Dosimeter for Personal Exposure Assessment1R43ES026474-01 | NAMENI, GORDON N | PLATYPUS TECHNOLOGIES, LLC, WI | $145,761 | ZRG1 |
| 2016 | Phase I Clinical trial with 4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Children with Cancer Involving the CNS1R43CA203351-01 | MORGAN, LEE ROY | DEKK-TEC, INC., LA | $90,362 | ZRG1 |
| 2015 | Mitochondrial DNA repair agents for acute lung injury2R44HL114225-02 | GILLESPIE, MARK NWILSON, GLENN | EXSCIEN CORPORATION, AL | $1,657,860 | ZRG1 |
| 2015 | External, High-Intensity Proton Injector with Ultra-Precise Control for Fast Spot Beam Scanning PBRT2R44CA196022-02 | ANTAYA, TIMOTHY A | ANTAYA SCIENCE AND TECHNOLOGY, NH | $1,651,320 | ZRG1 |
| 2015 | Micro-technology Enhanced Pediatric & Adult Lens Capsulotomy Device2R44EY021023-04 | HENDRICK, JOHN N | MYNOSYS CELLULAR DEVICES, INC., CA | $1,491,280 | ZRG1 |
| 2015 | LOW-COST FLEXIBLE SKIN-ADHESIVE PATCH FOR DIAGNOSING SLEEP DISORDERED BREATHING2R44HL123196-02 | MERCHANT, MARIA | SOMNARUS, INC., CA | $1,163,946 | ZRG1 |
| 2015 | Physics-Based Simulator to Teach Hands-On Vascular Surgical Skills2R44HL118939-02 | LENOIR, JULIEN | SIMQUEST INTERNATIONAL, LLC, MD | $1,120,938 | ZRG1 |
| 2015 | An immune-based approach for HIV eradication2R44AI100778-03 | INC., RETROVIROX | RETROVIROX, INC., CA | $1,108,021 | ZRG1 |
| 2015 | Immune modulation of radiation therapy with Flt3 ligand2R44CA192435-02 | GUHA, CHANDANKELER, TIBOR | CELLDEX THERAPEUTICS, INC., NJ | $1,081,749 | ZRG1 |
| 2015 | Interactive MR Image Guided Intervention (iMR-IGI) for Breast Applications2R44CA165407-02A1 | HARTER, RAYMOND DKELCZ, FREDERICK | MARVEL MEDTECH, LLC, WI | $1,020,481 | ZRG1 |
| 2015 | Protease-resistant D-peptide Inhibitors of Ebola Virus Entry2R44AI102347-03 | WELCH, BRETT D | NAVIGEN, INC., UT | $1,000,000 | ZRG1 |
| 2015 | In-Vitro Culture of Plasmodium falciparum Sporozoites for Malaria Vaccine2R44AI085740-03A1 | HOFFMAN, STEPHEN LEV | SANARIA, INC., MD | $999,996 | ZRG1 |
| 2015 | Genetically Attenuated PfSPZ Malaria Vaccine2R44AI069631-06A1 | HOFFMAN, STEPHEN LEV | SANARIA, INC., MD | $999,994 | ZRG1 |
| 2015 | Clinical and Non-Clinical Evaluations of repeat administrations of the FAST PV and mGFR Technology2R44DK093274-03A1 | MEIER, DANIELMOLITORIS, BRUCE A | PHARMACOPHOTONICS, INC., IN | $999,701 | ZRG1 |
| 2015 | A novel device for improving sepsis outcomes through hemodynamic optimization2R44GM108320-02 | BURNETT, DANIEL ROGERS | THERANOVA, LLC, CA | $998,356 | ZRG1 |
| 2015 | Molecular Detection of Invasive Fungal Infections2R44AI102343-03 | LEVIN, ANDREW E. | IMMUNETICS, INC., MA | $992,788 | ZRG1 |
| 2015 | CTC Purification System Based on Thermoresponsive NanoSubstrates2R44CA180482-02 | LIU, SEAN XIAOTSENG, HSIAN-RONGYANG, YAN | CYTOLUMINA TECHNOLOGIES CORPORATION, INC, CA | $992,352 | ZRG1 |
| 2015 | NOVEL ASSAY TO DETECT CHRONIC KIDNEY DISEASE2R44DK089892-06 | CARRITHERS, STEPHEN LCOUGHLIN, RICHARD THOMAS | SEQUELA, KY | $989,285 | ZRG1 |
| 2015 | High Cell Density Bioartificial Pancreas Enabled by Implantable Oxygen Generator2R44DK100999-02 | PAPAS, KLEARCHOS KTEMPELMAN, LINDA A | GINER, INC., MA | $984,736 | ZRG1 |
| 2015 | Low Cost Device for Detection of Retinal Disease2R44EY018772-04 | INGLING, ALLEN | AEON IMAGING, LLC, IN | $979,457 | ZRG1 |
| 2015 | Lateral Flow Assay for Diagnosis of Histoplasmosis2R44AI096945-03 | CRIDER, BEVERLY | IMMUNO-MYCOLOGICS, INC., OK | $972,745 | ZRG1 |
| 2015 | Optimization of novel pyranopyridine efflux pump inhibitors2R44AI100332-03A1 | OPPERMAN, TIMOTHY J. | MICROBIOTIX, INC, MA | $961,043 | ZRG1 |
| 2015 | Vision Restoration with Photoswitch Technology2R44EY019811-02A1 | TRAUTMAN, JAY K | PHOTOSWITCH BIOSCIENCES, INC., CA | $948,543 | ZRG1 |
| 2015 | Platform for MR-Guided Neurotherapeutic Drug Delivery2R44CA177205-02 | BARKER, EDWARD RAY | INSERT, INC., WI | $938,975 | ZRG1 |
| 2015 | Development of a standardized kit for the isolation, enrichment, and high-sensitivity profiling of circular RNAs in the nervous system2R44DA038993-02 | GLASSCOCK, JARRET | COFACTOR GENOMICS, LLC, MO | $918,668 | ZRG1 |
| 2015 | High-throughput single-cell sorting and sequencing with PACS2R44HG007814-02 | EASTBURN, DENNIS J | MISSION BIO, INC., CA | $904,733 | ZRG1 |
| 2015 | RetiVue WF - A Handheld, High-Resolution, Wide-field Retinal Imager2R44EY023505-02 | LAI, MINGNETLAND, PETER A | RETIVUE, VA | $903,376 | ZRG1 |
| 2015 | EXTENDED RELEASE TORSEMIDE: PHASE 22R44DK098856-02A1 | FEIG, PETER URIWILCOX, CHRISTOPHER | SARFEZ PHARMACEUTICALS, INC., VA | $896,260 | ZRG1 |
| 2015 | Micro Patterned Intraocular Lens Membrane for Reducing Incidence of PCO2R44EY022541-02A1 | CUEVAS, KEVINREDDY, SHRAVANTHI | SHARKLET TECHNOLOGIES, INC., CO | $887,124 | ZRG1 |
| 2015 | A luminal vascular coating to reduce time to maturation and failures of AV-Fistulas for hemodialysis access2R44DK100156-02 | KATHERINE STUART, KATHERINE STUARTROY-CHAUDHURY, PRABIR | SYMIC BIOMEDICAL, INC., CA | $850,756 | ZRG1 |
| 2015 | ASD Parent Trainer: Online coaching for parents of children with autism (APT)2R44MH102845-02 | CARAWAY, NELLHIENEMAN, MEME | IRIS MEDIA, INC., OR | $843,308 | ZRG1 |
| 2015 | Optical small animal imaging unit for quantification of bacterial infections2R44EB018644-02 | KLOSE, ALEXANDER D. | IN VIVO ANALYTICS, INC., NY | $841,446 | ZRG1 |
| 2015 | Enzyme replacement therapy for Sanfilippo A lysosomal rare disease2R44NS083230-02A1 | CONDORI, JOSE MARCOSCRAMER, CAROLE L.D'AZZO, ALESSANDRARADIN, DAVID | BIOSTRATEGIES, LC, AR | $831,740 | ZRG1 |
| 2015 | Adiponectin Secretion Enhancer Synthetic Organic Drug Discovery and Development2R44DK100183-02 | MAI, DEBORAHSTREIFF, JOHN H | DISCOVERYBIOMED, INC., AL | $812,130 | ZRG1 |
| 2015 | CMOS-Integrated Fluorescence Biochip SBIR Phase II Grant Application2R44HG007626-02 | HASSIBI, ARJANG | INSILIXA, INC., CA | $810,812 | ZRG1 |
| 2015 | Immunoassay for diagnosis of Babesia infection2R44AI100471-03 | LEVIN, ANDREW E. | IMMUNETICS, INC., MA | $808,595 | ZRG1 |
| 2015 | Radioactive Stents for Brachytherapy of Esophageal Cancers2R44CA171687-02 | PENG, YONGREN BENJAMIN | XL SCI-TECH, INC., WA | $802,308 | ZRG1 |
| 2015 | A MERS-CoV Receptor Decoy2R44AI114023-02A1 | WYCOFF, KEITH | PLANET BIOTECHNOLOGY, INC., CA | $801,833 | ZRG1 |
| 2015 | HIV B-Cell Lineage Vaccine Design Based on Replicating SAd and Env Protein in NHP2R44AI102787-03 | ALEXANDER, JEFFERYGURWITH, MARC JOSEPHSMITH, JONATHAN FOWLER | PAXVAX, INC., CA | $801,463 | VACC |
| 2015 | Intraoperative assessment of non-melanoma skin cancer margins using NIRF probes.2R44CA180296-02 | STRAIGHT, BRIAN | AKROTOME IMAGING, INC., NC | $792,080 | ZRG1 |
| 2015 | Design of a Covalent Inhibitor for c-Myc-Dependent Cancers2R44CA189499-02 | OUYANG, SHAWN XIAOHU | SUVALENT THERAPEUTICS, INC., CA | $788,879 | ZRG1 |
| 2015 | Social Support Aid for People with Dementia2R44AG041667-02A1 | HAVEY, GARY D | ADVANCED MEDICAL ELECTRONICS CORPORATION, MN | $786,053 | ZRG1 |
Showing the 200 most recent of 1,462 awards.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.